Oklo (OKLO) stock inched higher on Tuesday after the company said its subsidiary Atomic Alchemy has received its first-ever materials license from the Nuclear Regulatory Commission (NRC).

At its intraday peak, OKLO was seen trading above its 20-day moving average (MA), indicating a potential shift in short-term momentum from bearish to bullish.

Crude Oil Rallies as Iranian Attacks Disrupt Middle Eastern Supplies

Nat-Gas Prices Gain as Iran Attacks Key Energy Infrastructure

Crude Oil Prices Gain as Iran Renews Attacks on Middle East Energy Infrastructure

Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else.

Despite today’s gains, OKLO shares remain down over 40% versus their January high.

The NRC license is a watershed moment for OKLO stock as it validates the company’s path toward commercial isotope production.

Specifically, this materials license enables the NYSE-listed firm to handle and process isotopes at its Idaho Radiochemistry Laboratory.

While OKLO is primarily known for its Aurora power plants, this approval unlocks an immediate, secondary revenue stream in the medical and industrial isotope market.

By proving it can navigate the NRC’s rigorous safety and security standards, the company based out of Santa Clara, California, has de-risked its regulatory profile, boosting institutional confidence in its ability to eventually license its larger power reactors.

While OKLO reported a wider-than-expected per-share loss of $0.27 for its fourth financial quarter (Q4) today, the underlying details remain significantly positive for long-term investors.

The company finished 2025 with a fortress balance sheet, boasting over $1.1 billion in cash and equivalents, which provides a multi-year runway for data center deployment.

As of early 2026, the nuclear energy firm has established a remarkable 18GW pipeline that includes a number of high-density users like Meta Platforms (META).

It’s partly why options traders are currently pricing in significant upside in OKLO shares.

According to Barchart, contracts expiring mid-June have the upper price set at about $70, signaling the company’s share price could climb another 30% over the next three months.

Wall Street analysts seem to share options traders’ optimism on OKLO stock as well.

The consensus rating on this nuclear-tech firm sits at “Moderate Buy” currently with the mean target of about $108 indicating potential upside of nearly 80% from here.

This article was created with the support of automated content tools from our partners at Sigma.AI. Together, our financial data and AI solutions help us to deliver more informed market headline analysis to readers faster than ever.

On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com